Page last updated: 12th March 2024

The overall programme is overseen by the National Multidisciplinary Team (NMDT) of expert clinicians.

• Which children may access Zolgensma treatment?
• Where are the Infusion Centres?
• How does my child, newly diagnosed with SMA Type 1, access Zolgensma?​
• What’s happening for other eligible groups of children?
• How many children in total have been treated so far?
• Is another treatment after Zolgensma possible?

Our January 2024 webinar gives an update on progress with the programme in the UK: